Growth regulation by peroxisome proliferators: Opposing activities in early and late G1

Cancer Research

Volumn 56, Issue 14, 1996, Pages 3257-3264

  Ledwith, Brian J ^a   Johnson, Timothy E ^a   Wagner, Linda K ^a   Pauley, Cindy J ^a   Manam, Sujata ^a   Galloway, Sheila M ^a   Nichols, Warren W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PEROXISOME PROLIFERATOR;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CARCINOGENICITY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; DNA SYNTHESIS; GENE EXPRESSION; GENE INDUCTION; GROWTH REGULATION; IMMEDIATE EARLY GENE; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BEZAFIBRATE; CARCINOGENS; CELL CYCLE; CELL LINE; CLOFIBRATE; CLOFIBRIC ACID; DNA; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; GROWTH SUBSTANCES; MICE; MICROBODIES; PYRIMIDINES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 0030013157     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Ashby, J , Brady, A., Elcombe, C. R , Elliot, B. M., Ishmael, J , Odum, J., Tugwood, J. D , Kettle, S , and Purchase, I. F. H. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. & Exp Toxicol., 13 (Suppl. 2): S1-S117, 1994.
2. 2-generating peroxisomal fatty acyl-CoA oxidase. Proc. Natl. Acad. Sci. USA, 92. 7080-7084, 1995.
3. Sausen, P. J., Lee, D. C., Rose, M. L , and Cattley, R C. Elevated 8-hydroxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to mitochondrial alterations. Carcinogenesis (Lond.), 16: 1795-1801, 1995.
4. Popp, J. A., and Cattley, R C. Peroxisome proliferators as initiators and promoters of rodent hepatocarcinogenesis. In: G. G. Gibson and B. G. Lake (eds.), Peroxisomes: Biology and Importance in Toxicology and Medicine, pp. 653-665 London: Taylor & Francis, 1993
5. Grasl-Kraupp, B., Huber, W , Timmermann-Trosiener, I., and Schulte-Hermann, R. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisomal proliferator nafenopin. Carcinogenesis (Lond.), 14: 2435-2437, 1993
6. Cattley, R. C., Kato, M., Popp, J. A., Teets, V. J., and Voss, K. S. Initiator-specific promotion of hepatocarcinogenesis by Wy-14643 and clofibrate Carcinogenesis (Lond.), 15: 1763-1766, 1994.
7. Marsman, D. S., Cattley, R. C., Conway, J. G , and Popp, J. A Relationship between hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14643) in rats Cancer Res., 48: 6739-6744, 1988.
8. Wada, N., Marsman, D. S., and Popp, J. A. Dose-related effects of the hepatocarcinogen Wy-14643 on peroxisomes and cell replication. Fundam. Appl Toxicol , 18: 149-154, 1992.
9. Eacho, P. I., Lanier, T. L., and Brodhecker, C. A. Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of Wy-14643 to clofibric acid, nafenopin and LY171883 Carcinogenesis (Lond.), 12: 1557-1561, 1991
10. Barrass, N. C., Price, R. J , Lake, B. G., and Orton, T. C Comparison of the acute and chronic mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis (Lond), 14: 1451-1456, 1993.
11. Tanaka, K., Smith, P F., Stromberg, P. C., Eydelloth, R. S., Herold, E. G., Grossman, S. J , Frank, J. D , Hertzog, P. R., Soper, K. A., and Keenan, K. P. Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate. Toxicol. Appl. Pharmacol., 116: 71-77, 1992.
12. Chen, H , Huang, C., Wilson, M. W., Lay, L. T , Robertson, L W , Chow, C K., and Glauert, H. P. Effect of the peroxisomal proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats Carcinogenesis (Lond.), 15: 2847-2850, 1994
13. Grasl-Kraupp, B , Huber, W., Just, W., Gibson, G , and Schulte-Hermann, R. Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisomal proliferator nafenopin. Carcinogenesis (Lond.), 14: 1007-1012, 1993.
14. Chen, Z Y., Liu, Y. F., He, C. Y., White, C. C., and Eaton, D L. Inhibition of cell proliferation by ciprofibrate in glutathione-S-transferase P1-1-positive rat hepatic hyperplastic nodules. Cancer Res., 54: 2622-2629, 1994
15. Rao, M S , Subbarao, V , Yeldandi, A. V., and Reddy, J K. Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res., 52: 2977-2979, 1992.
16. Lindros, P , and Michalopoulos, G. K. Response of phenobarbital and ciprofibrate-exposed hepatocytes to growth factors in type I collagen gels. Carcinogenesis (Lond.), 14: 731-735, 1993.
17. Tanaka, K., Kawamura, S., Matsumoto, H , and Doi, K. Effects of chronic treatment with clofibric acid on response of rat hepatocytes to mitogenic stimuli. Toxicol. Lett., 74: 141-148, 1994
18. Bayly, A C., Roberts, R A , and Dive, C. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell Biol , 125: 197-203, 1994.
19. Roberts, R A , Soames, A. R., Gill, J H , James, N. H., and Wheeldon, E. B. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis (Lond.), 16: 1693-1698, 1995.
20. Green, S, PPAR: as mediator of peroxisome proliferator action. Mutat. Res , 333: 101-109, 1995
21. Issemann, I., Prince, R A., Tugwood, J. D , and Green, S. The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs J. Mol. Endocrinocrinol , 11: 37-47, 1993.
22. Lee, S S-T., Pineau, T., Drago, J., Lee, E. J , Owens, J. W., Kroetz, D L., Fernandez-Salguero, P. M., Westphal, H., and Gonzalez, F J Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol , 15: 3012-3022, 1995.
23. Graber, R , Sumida, C , and Nunez, E. A. Fatty acids and cell signal transduction J Lipid Mediators Cell Signalling, 9: 91-116, 1994.
24. Nishizuka, Y. Protein Kinase C and lipid signaling for sustained cellular responses FASEB J., 9: 484-496, 1995.
25. Casey, P J. Protein Lipidation in Cell Signalling. Science (Washington DC), 268: 221-225, 1995.
26. Lau, L. F , and Nathans, D Genes induced by serum growth factors. In: P. Cohen and J. G. Foulkes (eds.), The Hormonal Control Regulation of Gene Transcription, pp. 257-293. Amsterdam: Elsevier Science Publishers B.V., 1991.
27. Herschman, H R. Primary response genes induced by growth factors and tumor promoters Annu. Rev Biochem., 60: 281-319, 1991.
28. Ledwith, B J., Manam, S , Troilo, P., Joslyn, D. J , Galloway, S. M., and Nichols, W. W. Activation of immediate-early gene expression by peroxisome proliferators in vitro. Mol. Carcinog., 8: 20-27, 1993.
29. Patek, P. Q., Collins, J. L., and Cohn, M. Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis. Nature (Lond). 270: 510-511, 1978
30. Chomczynski, P , and Sacchi, N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem , 162: 156-159, 1987.
31. Mitchell, A. M., Lhuguenot, J C , Bridges, J. W., and Elcombe, C. R. Identification of the proximate peroxisome proliferators(s) derived from di(2-ethylhexyl)phthalate. Toxicol. Appl Pharmacol., 80: 23-32, 1985.
32. Yamada, J., Sakuma, M., Ikeda, T., and Suga, T Activation of dehydroepiandrosterone as a peroxisome proliferator by sulfate conjugation. Arch. Biochem. Biophys , 313 379-381, 1994.
33. Areces, L. B., Kazanietz, M. G., and Blumberg, P. M. Close similarity of baculovirus-expressed n-chimaerin and protein kinase Cα as phorbol ester receptors. J. Biol. Chem., 269: 19553-19558, 1994.
34. Schulz, S., Klann, R. C., Schonfeld, S., and Nyce, J. W. Mechanism of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone, role of isoprenoid biosynthesis. Cancer Res., 52, 1372-1376, 1992.
35. Schulz, S., and Nyce, J. W Inhibition of protein farnesyltransferase: a possible mechanism of tumor prevention by dehydroepiandrosterone sulfate. Carcinogenesis (Lond), 15: 2649-2652, 1994.
36. Styles, J. A., Bybee A., Pritchard, N. R , and Kelly, M. D. Studies on the hyperplastic responsiveness of binucleated rat hepatocytes. Carcinogenesis (Lond.), 11: 1149-1152, 1990.
37. Goodnight, J., Mischak, H., and Mushinski, S F. Selective involvement of protein kinase C isozymes in differentiation and neoplastic transformation. Adv. Cancer Res , 64: 159-209, 1994.
38. Zhou, W , Takuwa, N., Kumada, M., and Takuwa, Y. Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells. J. Biol. Chem., 268: 23041-23048, 1993.
39. Malki, M. C., Lone, Y C., Corral-Debrinski, M , and Latruffe, N Differential proto-oncogene mRNA induction from rats treated with peroxisome proliferators Biochem. Biophys. Res Commun., 173: 855-861, 1990.
40. Hsieh, L. L , Shinozuka, H., and Weinstein, I. B. Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisome proliferator Br J. Cancer, 64 815-820, 1991.
41. Angel, P , and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys Acta, 1072: 129-157, 1991.
42. Ghosh, T. K., Bian, S., Short, A. D., Rybak, S. L., and Gill, D L. Persistent intracellular calcium pool depletion by thapsigargin and its influence on cell growth. J. Biol. Chem., 266: 24690-24697, 1991.
43. Yokoyama, Y., Tsuchida, S., Hatayama, I., Satoh, K , Narita, T., Rao, M. S , Reddy, J. K., Yamada, J., Suga, T., and Sato, K Loss of peroxisomal enzyme expression in preneoplastic and neoplastic lesions induced by peroxisome proliferators in rat livers Carcinogenesis (Lond.), 13: 265-269, 1992.
44. Sakai, M., Matsushima-Hibiya, Y., Nishizawa, M , and Nishi, S. Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between Jun and peroxisome proliferator-activated receptor α. Cancer Res., 55: 5370-5376, 1995
45. Ochsner, M., Creba, J., Walker, J., Bentley, P., Fouad, S., and Muakkassah-Kelly, S. F Nafenopin. a hypolipidemic and non-genotoxic hepatocarcinogen, increases intracellular calcium and transiently decreases intracellular pH in hepatocytes without generation of inositol phosphates. Biochem Pharmacol., 40: 2247-2257, 1990
46. Shackelton, G. L., Gibson, G. G., Sharma, R K., Howes, D., Orrenius, S., and Kass, G. E. N. Diverse mechanisms of calcium mobilization by peroxisome proliferators in rat hepatocytes. Toxicol Appl. Pharmacol., 130: 294-303, 1995
47. 2+-ATPase activity and mobilization of hepatic intracellular calcium by ciprofibrate, a peroxisome poliferator. Biochem. Pharmacol , 43: 595-605, 1992.
48. 2+-ATPase thiol integrity by ciprofibrate, a peroxisome poliferator. Biochem Pharmacol., 45: 2093-2098, 1993.